6.1 Fundamentals of Immunology & Antigen-Antibody Reactions

Fundamentals of Immunology

Immunology is the study of the host's defense mechanisms against infectious agents, tumors, and other non-self substances. The clinical laboratory plays a vital role in assessing immune function and diagnosing immune-related diseases. Understanding the complex interplay between the various arms of the immune system is fundamental for any medical laboratory technician.

Innate vs. Adaptive Immunity

The immune system is broadly divided into two interrelated branches: innate (natural) and adaptive (acquired) immunity.

Innate Immunity

Innate Immunity is the body's first line of defense. It is primitive, present at birth, and provides an immediate, non-specific response to pathogens. Importantly, innate immunity does not generate immunological memory. Its components include:

• Physical and Chemical Barriers: Intact skin, mucous membranes, stomach acid (low pH), and antimicrobial enzymes like lysozyme (found in tears and saliva). Normal flora (microbiome) also acts as a biological barrier by competing with pathogens for space and nutrients.
• Cellular Components:
  • Neutrophils (PMNs): The most abundant white blood cell. They are the first responders to bacterial infections, engaging in diapedesis (extravasation) to reach tissues, followed by phagocytosis and destruction of bacteria via the respiratory burst (producing reactive oxygen species via myeloperoxidase).
  • Macrophages: Mononuclear phagocytes derived from circulating monocytes. They are tissue-resident (e.g., Kupffer cells in the liver, microglial cells in the brain, alveolar macrophages in the lungs) and act as scavenger cells and antigen-presenting cells.
  • Natural Killer (NK) Cells: Large granular lymphocytes that recognize and destroy virus-infected and malignant cells without prior sensitization. They recognize the absence of normal MHC Class I molecules on target cells.
• Humoral Components: The complement system (alternative and lectin pathways) and acute-phase proteins (e.g., C-Reactive Protein, fibrinogen) that rapidly increase during acute inflammation.
• Pattern Recognition Receptors (PRRs): Cells of the innate immune system use PRRs, such as Toll-Like Receptors (TLRs), to recognize highly conserved Pathogen-Associated Molecular Patterns (PAMPs) present on microbes (e.g., lipopolysaccharide on Gram-negative bacteria, or unmethylated CpG DNA).

Adaptive Immunity

Adaptive Immunity takes days to weeks to fully develop but offers a highly specific response to distinct antigens. A hallmark of adaptive immunity is immunological memory, leading to a faster and more vigorous secondary response upon re-exposure to the same antigen. This is driven by somatic recombination (V(D)J recombination) generating immense receptor diversity. Adaptive immunity is sub-divided into humoral and cell-mediated arms.

Humoral Immunity

Mediated primarily by B lymphocytes (B cells), which mature in the Bone Marrow. Humoral immunity defends against extracellular pathogens and toxins. When a naive B cell encounters its specific antigen, it undergoes clonal expansion and differentiates into:

• Plasma Cells: The effector cells that actively secrete large volumes of antigen-specific antibodies. They have abundant rough endoplasmic reticulum to support massive protein synthesis.
• Memory B Cells: Long-lived cells that remain in circulation to rapidly respond to future infections by differentiating into plasma cells without the need for extensive initial activation.

Cell-Mediated Immunity

Mediated by T lymphocytes (T cells), which originate in the bone marrow but mature in the Thymus. This branch is crucial for defense against intracellular pathogens (like viruses, mycobacteria), fungal infections, and tumor cells. T cells recognize antigens only when presented by Major Histocompatibility Complex (MHC) molecules on antigen-presenting cells (APCs). Major subsets include:

• Helper T Cells (CD4+): Recognize antigens presented on MHC Class II molecules (HLA-DP, DQ, DR). They act as the "generals" of the immune system, secreting cytokines that direct and activate B cells, cytotoxic T cells, and macrophages.
• Cytotoxic T Cells (CD8+): Recognize antigens presented on MHC Class I molecules (HLA-A, B, C, found on virtually all nucleated cells). They directly induce apoptosis in virus-infected or malignant host cells via perforin and granzymes.

Immunoglobulin Structure & Classes

Antibodies, or immunoglobulins (Ig), are glycoproteins produced by plasma cells. The basic monomeric structure is a "Y" shape composed of four polypeptide chains held together by disulfide bonds: two identical heavy chains and two identical light chains (kappa or lambda).

• Fab Region (Fragment antigen-binding): The variable "arms" of the Y that contain the specific antigen-binding sites. This region determines the antibody's unique idiotype.
• Fc Region (Fragment crystallizable): The constant "stem" of the Y that determines the immunoglobulin class (isotype) and mediates effector functions, such as complement fixation (binding C1q) and binding to Fc receptors on phagocytes (opsonization).

The Five Immunoglobulin Classes

1. IgG (Gamma heavy chains): The most abundant immunoglobulin in serum (75-80%). It is a 150 kDa monomer that provides long-term immunity. IgG is unique because it is the only class that can cross the placenta, providing crucial passive immunity to the developing fetus and newborn for the first few months of life. It is the major antibody of the secondary (anamnestic) immune response.
2. IgM (Mu heavy chains): The first antibody produced during a primary immune response. While it exists as a monomer on the surface of B cells, secreted IgM is a massive 900 kDa pentamer (five basic units joined by a J chain), yielding 10 potential antigen-binding sites. Because of its large size, it is restricted to the intravascular space and cannot cross the placenta. It is the most efficient class for triggering the classical complement pathway and causing visible agglutination.
3. IgA (Alpha heavy chains): The predominant antibody in bodily secretions (tears, saliva, colostrum, breast milk, and mucosal secretions of the respiratory and GI tracts). In serum, it is a monomer, but in secretions, it exists as a dimer held together by a J chain and protected by a Secretory Component, which prevents enzymatic degradation in harsh mucosal environments.
4. IgE (Epsilon heavy chains): A monomer present in trace amounts in normal serum. The Fc portion of IgE binds strongly to specific receptors on mast cells and basophils. Upon binding specific allergens, IgE triggers cellular degranulation and the massive release of histamine and leukotrienes, mediating Type I hypersensitivity (allergic and anaphylactic) reactions. It also plays a key role in defense against parasitic helminths.
5. IgD (Delta heavy chains): A monomer found in very low concentrations in serum. Its primary function is serving as a surface antigen receptor on mature, naive B cells, assisting in their activation. Its exact role in free serum remains poorly understood.

Complement Pathways

The complement system is a complex cascade of over 30 serum and membrane proteins that orchestrate inflammation, opsonization, and direct pathogen lysis. The proteins circulate in an inactive (zymogen) form and are activated sequentially in a cascading amplifier mechanism. All three activation pathways converge at the formation of C3 convertase, leading to the cleavage of C3 into C3a (anaphylatoxin) and C3b (potent opsonin). This leads to the terminal formation of the Membrane Attack Complex (MAC), consisting of complement components C5b, C6, C7, C8, and multiple C9 molecules, which punches lethal holes in target cell membranes.

1. Classical Pathway: An effector arm of adaptive immunity. Activated by antigen-antibody complexes. Specifically, it requires the binding of C1q to the Fc portion of either one IgM pentamer or at least two closely spaced IgG molecules bound to an antigen on a cell surface. The classical C3 convertase is C4b2a.
2. Alternative Pathway: Part of innate immunity, it is activated spontaneously by contact with foreign surfaces, such as bacterial lipopolysaccharide (LPS) or yeast cell walls, independent of antibodies. The alternative C3 convertase is C3bBb.
3. Lectin Pathway: Also antibody-independent, it is initiated when soluble plasma proteins called Mannose-Binding Lectin (MBL) bind to mannose and other terminal carbohydrate residues uniquely found on the surfaces of pathogens, acting analogously to C1q.

Anaphylatoxins: The small fragments C3a, C4a, and C5a act as potent inflammatory mediators, triggering mast cell degranulation and inducing smooth muscle contraction and increased vascular permeability. C5a is additionally a potent chemotactic factor, drawing neutrophils to the site of infection.

Antigen-Antibody Reaction Kinetics

Serological testing relies on the highly specific, reversible interaction between antigens and antibodies. These interactions are governed by weak, non-covalent forces (hydrogen bonds, electrostatic forces, Van der Waals forces, and hydrophobic interactions).

• Affinity: The thermodynamic quantity representing the initial force of attraction between a single antigenic determinant (epitope) and a single corresponding antibody binding site.
• Avidity: The cumulative, overall strength of binding between a multivalent antigen and a multivalent antibody. An IgM molecule, with its 10 binding sites, has lower affinity at any single site but a vastly higher overall avidity compared to a monomeric IgG.
• Cross-Reactivity: Occurs when an antibody generated against one specific antigen binds to a different, but structurally similar, antigen. This is a common source of biological false positives in serological assays.

Lattice Formation and Zoning Phenomenon

For many classical immunoassays (agglutination and precipitation) to yield a visible positive result, a massive, insoluble cross-linked network of antigen and antibody, called a lattice, must form. Lattice formation requires optimal proportions of antigen and antibody.

• Zone of Equivalence: The optimal ratio where the number of multivalent sites of antigen and antibody are approximately equal, allowing for maximum lattice formation and the strongest visible reaction.
• Prozone Phenomenon (Antibody Excess): Occurs when a patient has very high titers of antibody. The excess antibodies rapidly saturate all antigen sites on individual particles before cross-linking between distinct particles can occur. This results in small complexes that do not precipitate or agglutinate, causing a false-negative result in a patient who is actually highly positive. Resolution: Serially dilute the patient's serum and retest to force the ratio back into the zone of equivalence.
• Postzone Phenomenon (Antigen Excess): Occurs when there is an overwhelming amount of antigen compared to antibody. Small immune complexes form, but there is insufficient antibody to bridge them into large cross-links, again causing a false-negative. Resolution: Retest the patient using a newly drawn sample a week or two later, allowing time for more antibodies to be produced naturally.

Immunoassay Methodologies

Modern serology employs various methods to detect and quantify antigens or antibodies. The choice of method depends on the required sensitivity, specificity, and turnaround time.

• Agglutination: The visible clumping of particulate, insoluble antigens (e.g., intact bacteria, red blood cells, latex particles) when cross-linked by specific antibodies. Hemagglutination refers specifically to red blood cell agglutination, widely used in blood banking.
• Precipitation: The formation of an insoluble, visible complex when a soluble, molecular antigen reacts with a soluble antibody in an aqueous or gel medium. Examples include Ouchterlony double immunodiffusion and radial immunodiffusion (RID).
• Enzyme-Linked Immunosorbent Assay (ELISA) / EIA: A highly sensitive, solid-phase technique utilizing antibodies or antigens conjugated to an enzyme (like horseradish peroxidase or alkaline phosphatase). Following incubation and washing steps to remove unbound components, a colorless chromogenic substrate is added. The bound enzyme converts the substrate into a colored product. The intensity of the color is measured spectrophotometrically and is directly proportional to the analyte concentration. ELISA can be direct, indirect, competitive, or a "sandwich" assay.
• Immunofluorescence Assay (IFA): Employs antibodies conjugated to fluorescent dyes (fluorochromes), most commonly fluorescein isothiocyanate (FITC). When exposed to ultraviolet light under a fluorescence microscope, the fluorochrome emits visible light (e.g., an apple-green fluorescence). In indirect IFA, a known antigen substrate fixed on a slide is exposed to patient serum, followed by washing and the addition of a fluorescently labeled anti-human globulin. It is the gold standard for ANA testing.
• Chemiluminescence: Currently the method of choice for many automated, high-throughput serology analyzers due to its superior sensitivity and exceptionally wide dynamic range. It utilizes labels (like acridinium esters) that, when oxidized by specific trigger reagents, undergo a chemical reaction that briefly emits a flash of light. The emitted light is measured by a photomultiplier tube (PMT) and correlates linearly with the amount of analyte in the sample.
• Flow Cytometry: A laser-based technique used for cell counting, sorting, and biomarker detection. Cells are suspended in a stream of fluid and passed one by one through a laser beam. Antibodies labeled with various fluorochromes (FITC, PE, APC, PerCP) bind to specific cell surface markers (like CD4 or CD8). The scattered light provides information on cell size and internal complexity, while fluorescence emissions identify specific cell populations. It is the definitive method for calculating CD4 counts in HIV patients.